Bacteriophages Therapy Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 170 Category: Pharma & Healthcare Report Code : HC0316911
Bacteriophages Therapy Market By Type (Escherichia Coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, Others) and Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Bacteriophages Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Bacteriophages are the natural enemies of bacteria. The word bacteriophage means bacteria eater. Bacteriophages kill bacteria by making them burst or lyse. This happens when the virus binds to the bacteria.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Bacteriophages Therapy Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Armata Pharmaceuticals, Inc.
- iNtODEWORLD, Inc,
- Phage International, Inc
- Fixed-Phage Limited
- LOCUS BIOSCIENCES, INC.
- Pherecydes Pharma
- Adaptive Phage Therapeutics, Inc.
- Intralytix, Phagelux, Inc.
- PhagoMed Biopharma GmbH
- ContraFect Corporation
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Bacteriophages Therapy Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Escherichia Coli
o Staphylococcus
o Streptococcus
o Pseudomonas
o Salmonella
o Others
· Bacteriophages Therapy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Diagnostic
o Antimicrobial Drug Discovery
o Veterinary Medicines
o Others
· Bacteriophages Therapy Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Armata Pharmaceuticals, Inc.
o iNtODEWORLD, Inc,
o Phage International, Inc
o Fixed-Phage Limited
o LOCUS BIOSCIENCES, INC.
o Pherecydes Pharma
o Adaptive Phage Therapeutics, Inc.
o Intralytix, Phagelux, Inc.
o PhagoMed Biopharma GmbH
o ContraFect Corporation
· Bacteriophages Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Bacteriophages Therapy Market, By Country
o U.S. Bacteriophages Therapy Market
o Canada Bacteriophages Therapy Market
o Mexico Bacteriophages Therapy Market
o Europe
§ Europe Bacteriophages Therapy Market, By Country
o UK Bacteriophages Therapy Market
o Germany Bacteriophages Therapy Market
o France Bacteriophages Therapy Market
o Russia Bacteriophages Therapy Market
o Italy Bacteriophages Therapy Market
o Rest of Europe Bacteriophages Therapy Market
o Asia-Pacific
§ Asia-Pacific Bacteriophages Therapy Market, By Country
o China Bacteriophages Therapy Market
o Japan Bacteriophages Therapy Market
o South Korea Bacteriophages Therapy Market
o India Bacteriophages Therapy Market
o Southeast Asia Bacteriophages Therapy Market
o Rest of Asia-Pacific Bacteriophages Therapy Market
o South America
§ South America Bacteriophages Therapy Market
o Brazil Bacteriophages Therapy Market
o Argentina Bacteriophages Therapy Market
o Columbia Bacteriophages Therapy Market
o Rest of South America Bacteriophages Therapy Market
o Middle East and Africa
§ Middle East and Africa Bacteriophages Therapy Market
o Saudi Arabia Bacteriophages Therapy Market
o UAE Bacteriophages Therapy Market
o Egypt Bacteriophages Therapy Market
o Nigeria Bacteriophages Therapy Market
o South Africa Bacteriophages Therapy Market
o Turkey Bacteriophages Therapy Market
o Rest of MEA Bacteriophages Therapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Bacteriophages Therapy Market, By Type
5.1. Introduction
5.2. Global Bacteriophages Therapy Revenue and Market Share by Type (2017-2021)
5.2.1. Global Bacteriophages Therapy Revenue and Revenue Share by Type (2017-2021)
5.3. Escherichia Coli
5.3.1. Global Escherichia Coli Revenue and Growth Rate (2017-2021)
5.4. Staphylococcus
5.4.1. Global Staphylococcus Revenue and Growth Rate (2017-2021)
5.5. Streptococcus
5.5.1. Global Streptococcus Revenue and Growth Rate (2017-2021)
5.6. Pseudomonas
5.6.1. Global Pseudomonas Revenue and Growth Rate (2017-2021)
5.7. Salmonella
5.7.1. Global Salmonella Revenue and Growth Rate (2017-2021)
5.8. Others
5.8.1. Global Others Revenue and Growth Rate (2017-2021)
6. Bacteriophages Therapy Market, By Applications
6.1. Introduction
6.2. Global Bacteriophages Therapy Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Bacteriophages Therapy Revenue and Revenue Share by Applications (2017-2021)
6.3. Diagnostic
6.3.1. Global Diagnostic Revenue and Growth Rate (2017-2021)
6.4. Antimicrobial Drug Discovery
6.4.1. Global Antimicrobial Drug Discovery Revenue and Growth Rate (2017-2021)
6.5. Veterinary Medicines
6.5.1. Global Veterinary Medicines Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Bacteriophages Therapy Market, By Region
7.1. Introduction
7.2. Global Bacteriophages Therapy Revenue and Market Share by Regions
7.2.1. Global Bacteriophages Therapy Revenue by Regions (2017-2021)
7.3. North America Bacteriophages Therapy by Countries
7.3.1. North America Bacteriophages Therapy Revenue and Growth Rate (2017-2021)
7.3.2. North America Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Bacteriophages Therapy by Countries
7.4.1. Europe Bacteriophages Therapy Revenue and Growth Rate (2017-2021)
7.4.2. Europe Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Bacteriophages Therapy by Countries
7.5.1. Asia-Pacific Bacteriophages Therapy Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Bacteriophages Therapy by Countries
7.6.1. South America Bacteriophages Therapy Revenue and Growth Rate (2017-2021)
7.6.2. South America Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Bacteriophages Therapy by Countries
7.7.1. Middle East and Africa Bacteriophages Therapy Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Armata Pharmaceuticals, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. iNtODEWORLD, Inc,
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Phage International, Inc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Fixed-Phage Limited
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. LOCUS BIOSCIENCES, INC.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Pherecydes Pharma
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Adaptive Phage Therapeutics, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Intralytix, Phagelux, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. PhagoMed Biopharma GmbH
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. ContraFect Corporation
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Bacteriophages Therapy Market Forecast (2022-2027)
9.1. Global Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Bacteriophages Therapy Market Forecast by Regions (2022-2027)
9.2.1. North America Bacteriophages Therapy Market Forecast (2022-2027)
9.2.1.1. United States Bacteriophages Therapy Market Forecast (2022-2027)
9.2.1.2. Canada Bacteriophages Therapy Market Forecast (2022-2027)
9.2.1.3. Mexico Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2. Europe Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.1. Germany Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.2. France Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.3. UK Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.4. Russia Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.5. Italy Bacteriophages Therapy Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3. Asia-Pacific Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.1. China Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.2. Japan Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.3. Korea Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.4. India Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Bacteriophages Therapy Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Bacteriophages Therapy Market Forecast (2022-2027)
9.2.4. South America Bacteriophages Therapy Market Forecast (2022-2027)
9.2.4.1. Brazil Bacteriophages Therapy Market Forecast (2022-2027)
9.2.4.2. Argentina Bacteriophages Therapy Market Forecast (2022-2027)
9.2.4.3. Columbia Bacteriophages Therapy Market Forecast (2022-2027)
9.2.4.4. Rest of South America Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5. Middle East and Africa Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.3. Egypt Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.4. Nigeria Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.5. South Africa Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.6. Turkey Bacteriophages Therapy Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Bacteriophages Therapy Market Forecast (2022-2027)
9.3. Bacteriophages Therapy Market Forecast by Type (2022-2027)
9.3.1. Bacteriophages Therapy Forecast by Type (2022-2027)
9.3.2. Bacteriophages Therapy Market Share Forecast by Type (2022-2027)
9.4. Bacteriophages Therapy Market Forecast by Applications (2022-2027)
9.4.1. Bacteriophages Therapy Forecast by Applications (2022-2027)
9.4.2. Bacteriophages Therapy Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Bacteriophages Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Bacteriophages Therapy Revenue and Revenue Share by Type (2017-2019)
Figure Global Escherichia Coli Revenue and Growth Rate (2017-2019)
Figure Global Staphylococcus Revenue and Growth Rate (2017-2019)
Figure Global Streptococcus Revenue and Growth Rate (2017-2019)
Figure Global Pseudomonas Revenue and Growth Rate (2017-2019)
Figure Global Salmonella Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Bacteriophages Therapy Revenue and Revenue Share by Applications (2017-2019)
Figure Global Diagnostic Revenue and Growth Rate (2017-2019)
Figure Global Antimicrobial Drug Discovery Revenue and Growth Rate (2017-2019)
Figure Global Veterinary Medicines Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Bacteriophages Therapy Revenue by Regions (2017-2019)
Figure North America Bacteriophages Therapy Growth Rate (2017-2019)
Figure North America Bacteriophages Therapy Revenue and Growth Rate (2017-2019)
Figure North America Bacteriophages Therapy by Countries (2017-2019)
Figure North America Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2019)
Figure United States Bacteriophages Therapy Growth Rate (2017-2019)
Figure United States Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Bacteriophages Therapy Growth Rate (2017-2019)
Figure Canada Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Bacteriophages Therapy Growth Rate (2017-2019)
Figure Mexico Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Bacteriophages Therapy Growth Rate (2017-2019)
Figure Europe Bacteriophages Therapy Revenue and Growth Rate (2017-2019)
Figure Europe Bacteriophages Therapy by Countries (2017-2019)
Figure Europe Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Germany Bacteriophages Therapy Growth Rate (2017-2019)
Figure Germany Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Bacteriophages Therapy Growth Rate (2017-2019)
Figure France Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Bacteriophages Therapy Growth Rate (2017-2019)
Figure UK Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Bacteriophages Therapy Growth Rate (2017-2019)
Figure Russia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Bacteriophages Therapy Growth Rate (2017-2019)
Figure Italy Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Bacteriophages Therapy Growth Rate (2017-2019)
Figure Rest of Europe Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Bacteriophages Therapy Growth Rate (2017-2019)
Figure Asia-Pacific Bacteriophages Therapy Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Bacteriophages Therapy by Countries (2017-2019)
Figure Asia-Pacific Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2019)
Figure China Bacteriophages Therapy Growth Rate (2017-2019)
Figure China Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Bacteriophages Therapy Growth Rate (2017-2019)
Figure Japan Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Bacteriophages Therapy Growth Rate (2017-2019)
Figure Korea Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Bacteriophages Therapy Growth Rate (2017-2019)
Figure India Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Bacteriophages Therapy Growth Rate (2017-2019)
Figure Southeast Asia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Bacteriophages Therapy Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Bacteriophages Therapy Growth Rate (2017-2019)
Figure South America Bacteriophages Therapy Revenue and Growth Rate (2017-2019)
Figure South America Bacteriophages Therapy by Countries (2017-2019)
Figure South America Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Bacteriophages Therapy Growth Rate (2017-2019)
Figure Brazil Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Bacteriophages Therapy Growth Rate (2017-2019)
Figure Argentina Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Bacteriophages Therapy Growth Rate (2017-2019)
Figure Columbia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Bacteriophages Therapy Growth Rate (2017-2019)
Figure Rest of South America Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Bacteriophages Therapy Growth Rate (2017-2019)
Figure Middle East and Africa Bacteriophages Therapy Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Bacteriophages Therapy by Countries (2017-2019)
Figure Middle East and Africa Bacteriophages Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Bacteriophages Therapy Growth Rate (2017-2019)
Figure Saudi Arabia Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Bacteriophages Therapy Growth Rate (2017-2019)
Figure United Arab Emirates Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Bacteriophages Therapy Growth Rate (2017-2019)
Figure Egypt Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Bacteriophages Therapy Growth Rate (2017-2019)
Figure Nigeria Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Bacteriophages Therapy Growth Rate (2017-2019)
Figure South Africa Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Bacteriophages Therapy Growth Rate (2017-2019)
Figure Turkey Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Bacteriophages Therapy Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Table Armata Pharmaceuticals, Inc. Bacteriophages Therapy Financial Overview
Table iNtODEWORLD, Inc, Bacteriophages Therapy Financial Overview
Table Phage International, Inc Bacteriophages Therapy Financial Overview
Table Fixed-Phage Limited Bacteriophages Therapy Financial Overview
Table LOCUS BIOSCIENCES, INC. Bacteriophages Therapy Financial Overview
Table Pherecydes Pharma Bacteriophages Therapy Financial Overview
Table Adaptive Phage Therapeutics, Inc. Bacteriophages Therapy Financial Overview
Table Intralytix, Phagelux, Inc. Bacteriophages Therapy Financial Overview
Table PhagoMed Biopharma GmbH Bacteriophages Therapy Financial Overview
Table ContraFect Corporation Bacteriophages Therapy Financial Overview
Figure Global Bacteriophages Therapy Revenue (Millions USD) and Growth Rate (2019-2027)
Table Bacteriophages Therapy Market Forecast by Regions (2019-2027)
Figure North America Bacteriophages Therapy Market Forecast (2019-2027)
Figure United States Bacteriophages Therapy Market Forecast (2019-2027)
Figure Canada Bacteriophages Therapy Market Forecast (2019-2027)
Figure Mexico Bacteriophages Therapy Market Forecast (2019-2027)
Figure Europe Bacteriophages Therapy Market Forecast (2019-2027)
Figure Germany Bacteriophages Therapy Market Forecast (2019-2027)
Figure France Bacteriophages Therapy Market Forecast (2019-2027)
Figure UK Bacteriophages Therapy Market Forecast (2019-2027)
Figure Russia Bacteriophages Therapy Market Forecast (2019-2027)
Figure Italy Bacteriophages Therapy Market Forecast (2019-2027)
Figure Rest of Europe Bacteriophages Therapy Market Forecast (2019-2027)
Figure Asia-Pacific Bacteriophages Therapy Market Forecast (2019-2027)
Figure China Bacteriophages Therapy Market Forecast (2019-2027)
Figure Japan Bacteriophages Therapy Market Forecast (2019-2027)
Figure Korea Bacteriophages Therapy Market Forecast (2019-2027)
Figure India Bacteriophages Therapy Market Forecast (2019-2027)
Figure Southeast Asia Bacteriophages Therapy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Bacteriophages Therapy Market Forecast (2019-2027)
Figure South America Bacteriophages Therapy Market Forecast (2019-2027)
Figure Brazil Bacteriophages Therapy Market Forecast (2019-2027)
Figure Argentina Bacteriophages Therapy Market Forecast (2019-2027)
Figure Columbia Bacteriophages Therapy Market Forecast (2019-2027)
Figure Rest of South America Bacteriophages Therapy Market Forecast (2019-2027)
Figure Middle East and Africa Bacteriophages Therapy Market Forecast (2019-2027)
Figure Saudi Arabia Bacteriophages Therapy Market Forecast (2019-2027)
Figure United Arab Emirates Bacteriophages Therapy Market Forecast (2019-2027)
Figure Egypt Bacteriophages Therapy Market Forecast (2019-2027)
Figure Nigeria Bacteriophages Therapy Market Forecast (2019-2027)
Figure South Africa Bacteriophages Therapy Market Forecast (2019-2027)
Figure Turkey Bacteriophages Therapy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Bacteriophages Therapy Market Forecast (2019-2027)
Figure Global Bacteriophages Therapy Forecast by Type (2019-2027)
Figure Global Bacteriophages Therapy Market Share Forecast by Type (2019-2027)
Figure Global Bacteriophages Therapy Forecast by Type (2019-2027)
Figure Global Bacteriophages Therapy Forecast by Applications (2019-2027)
Figure Global Bacteriophages Therapy Market Share Forecast by Applications (2019-2027)
Figure Global Bacteriophages Therapy Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|